(Q39467786)

12 September 2017

1 reference

title

Bleeding in renal failure. (English)

1 reference

12 September 2017

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 May 1988

1 reference

12 September 2017

1 reference

12 September 2017

volume

1

1 reference

12 September 2017

issue

8596

1 reference

12 September 2017

page(s)

1205-1208

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

12 September 2017

1 reference

7 January 2021

Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Platelet count and thrombopoietic activity in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Bleeding in renal failure: a possible cause

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Bleeding in renal failure: is von Willebrand factor implicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

The bleeding disorder of uraemia. A qualitative platelet defect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

A clinical and experimental study of platelet function in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Specific Binding Sites on Human Blood Platelets for Plasma Lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Adenylate cyclase activity and cAMP content of human platelets in uraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Elevated thrombocyte calcium content in uremia and its correction by 1 alpha(OH) vitamin D treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Parathyroid hormone inhibits human platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Tissue distribution of electrolytes, 47ca and 28mg in experimental hyper- and hypoparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Impaired Platelet Thromboxane Production in Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Prostacyclin-like activity and bleeding in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Conjugated Estrogens for the Management of Bleeding Associated with Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Reduction of thrombus formation on dialyser membranes by aspirin and RA 233

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

MODERATE DOSES OF ASPIRIN AND RISK OF BLEEDING IN RENAL FAILURE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Upper gastrointestinal disease in chronic renal failure. A prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Upper gastrointestinal bleeding in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

A survey of 499 patients with acute anuric renal insufficiency. Causes, treatment, complications and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Spontaneous rupture of the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Spontaneous bilateral perirenal hematoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Spontaneous rupture of the kidney. A case of atraumatic retroperitoneal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

URAEMIC PERICARDITIS WITH CARDIAC TAMPONADE: A REPORT OF FOUR CASES.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Uremic pleural effusion. A study in 14 patients on chronic dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Subcapsular liver hematomas in a patient on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Subdural Hematoma During Long-Term Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Prostacyclin substitution for heparin in long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Hemodialysis without anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Treatment of the bleeding tendency in uremia with cryoprecipitate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Intranasal Deamino-8-<i>D</i>-Arginine Vasopressin Shortens the Bleeding Time in Uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Reduced response of uraemic bleeding time to repeated doses of desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Treatment of uraemic bleeding with conjugated oestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2992019-3

7 January 2021

10.1016/S0140-6736(88)92019-3

Identifiers

DOI

1 reference

12 September 2017

1 reference